• 1. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 2. An AuNPs-functionalized AlGaN/GaN high electron mobility transistor sensor for ultrasensitive detection of TNT?
  Ying Li,Weirong Yao,Yunfei Xie,Renjun Pei RSC Adv., 2015,5, 98724-98729
• 3. Achieving excellent anti-corrosion and tribological performance by tailoring the surface morphology and chemical composition of aluminum alloys
  Wenjie Zhao,Hua Hou,Yuchun Jin,Zhixiang Zeng,Xuedong Wu,Qunji Xue RSC Adv., 2014,4, 60307-60315
• 4. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 5. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Hydroxyquinolones
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Quinolones and derivatives Hydroxyquinolones

Introduction to 7-hydroxy-1,2-dihydroquinolin-2-one (CAS No. 70500-72-0)

7-hydroxy-1,2-dihydroquinolin-2-one is a significant compound in the field of pharmaceutical chemistry and medicinal biology, renowned for its versatile applications in drug discovery and development. This heterocyclic organic molecule, with the chemical formula C?H?NO?, belongs to the quinoline derivative family, a class of compounds widely studied for their pharmacological properties. The presence of both hydroxyl and carbonyl functional groups makes it a valuable intermediate in synthesizing various bioactive molecules.

The compound is identified by its unique Chemical Abstracts Service (CAS) number, 70500-72-0, which distinguishes it from other isomers and analogs in the chemical database. Its molecular structure consists of a fused ring system comprising a benzene ring and a pyridine ring, with hydroxyl and ketone functionalities strategically positioned to enhance reactivity and biological activity. This structural motif is commonly found in many pharmacologically active agents, contributing to its potential therapeutic applications.

In recent years, 7-hydroxy-1,2-dihydroquinolin-2-one has garnered attention in academic research due to its role as a precursor in the synthesis of novel antimicrobial and anticancer agents. The quinoline scaffold is well-documented for its ability to interact with biological targets such as DNA gyrase and topoisomerases, which are crucial in bacterial and cancer cell proliferation. Researchers have leveraged this compound to develop derivatives with enhanced efficacy and reduced toxicity.

One of the most compelling aspects of 7-hydroxy-1,2-dihydroquinolin-2-one is its versatility in chemical modifications. The hydroxyl group at the 7-position can undergo various reactions, including etherification, esterification, and sulfation, allowing chemists to tailor its properties for specific applications. Similarly, the carbonyl group at the 2-position can be reduced or oxidized to introduce additional functional diversity. These modifications have enabled the synthesis of a wide array of derivatives that exhibit promising biological activities.

Recent studies have highlighted the compound's potential in addressing emerging infectious diseases. The rise of antibiotic-resistant bacteria has necessitated the discovery of novel antimicrobial agents, and quinoline derivatives have emerged as a promising class of compounds. 7-hydroxy-1,2-dihydroquinolin-2-one has been investigated for its ability to inhibit bacterial enzymes involved in DNA replication and transcription. Preliminary results suggest that certain derivatives exhibit potent activity against Gram-negative pathogens, making them attractive candidates for further development.

The compound's significance extends beyond antimicrobial applications. It has also been explored as a precursor in the development of anticancer drugs. Quinoline derivatives are known for their ability to induce apoptosis in cancer cells by disrupting microtubule formation and inhibiting key signaling pathways. Researchers have synthesized analogs of 7-hydroxy-1,2-dihydroquinolin-2-one that show selective toxicity toward tumor cells while sparing healthy tissues. This selective toxicity is critical for improving patient outcomes in cancer therapy.

The synthesis of 7-hydroxy-1,2-dihydroquinolin-2-one itself is an area of active research. Multiple synthetic routes have been developed over the years, each with distinct advantages in terms of yield, purity, and scalability. One common approach involves the condensation of 2-formylphenol with glyoxal under basic conditions, followed by cyclization to form the dihydroquinoline core. Alternatively, palladium-catalyzed cross-coupling reactions have been employed to introduce additional functional groups with high precision.

The pharmaceutical industry has taken note of these advancements and is increasingly investing in the development of quinoline-based drugs. Companies are collaborating with academic institutions to explore new derivatives of 7-hydroxy-1,2-dihydroquinolin-2-one with improved pharmacokinetic profiles and reduced side effects. This collaborative effort underscores the compound's potential as a cornerstone in modern drug discovery.

From a regulatory perspective, 7-hydroxy-1,2-dihydroquinolin-2-one (CAS No. 70500-72-0) must comply with stringent quality standards set by agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Manufacturers must ensure that their synthetic processes meet these standards to guarantee safety and efficacy in final drug products. Continuous monitoring and optimization of production methods are essential to maintain high-quality standards throughout the supply chain.

The future prospects for 7-hydroxy-1,2-dihydroquinolin-2-one are promising given its broad applicability in pharmaceutical chemistry. As research progresses, new derivatives with enhanced therapeutic profiles are likely to emerge. Additionally, advancements in computational chemistry may accelerate the design and synthesis of novel analogs by predicting their biological activities before experimental testing.

In conclusion,7-hydroxy-1,2-dihydroquinolin-2-one represents a cornerstone compound in medicinal chemistry with far-reaching implications for human health. Its structural versatility allows for the creation of diverse bioactive molecules targeting various diseases. As research continues to uncover new applications for this compound,its importance is poised to grow further within both academic research communities and pharmaceutical industries worldwide.

• 10380-28-6(Copper quinolate)
• 1321-40-0(2-(1H)-Quinolinone)
• 59-31-4(2-HYDROXYQUINOLINE)
• 19315-93-6(quinoline-2,6-diol)
• 70254-42-1(2-Quinolinol)
• 84087-01-4(Quinclorac)
• 99-93-4(1-(4-Hydroxyphenyl)ethanone)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)